BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1339876)

  • 1. [How to improve the results in colorectal cancer?].
    Daher M
    J Med Liban; 1992; 40(2):100-2. PubMed ID: 1339876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serological markers of colorectal cancer].
    Nielsen HJ; Christensen IJ; Brünner NA
    Ugeskr Laeger; 2005 Oct; 167(44):4163-7. PubMed ID: 16266568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant therapy of colorectal carcinoma--1998 status].
    Borner M; Maurer C
    Schweiz Med Wochenschr; 1998 May; 128(20):763-9. PubMed ID: 9642751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting survival in surgical palliative resection of stage IV colorectal cancer.
    Scabini S; Rimini E; Romairone E; Scordamaglia R; Pertile D; Ferrando V
    Minerva Chir; 2009 Jun; 64(3):303-6. PubMed ID: 19536056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer].
    Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multidisciplinary therapy of colorectal cancer].
    Balogh A; Kahán Z; Maráz A; Mikó T; Nagy F; Palkó A; Thurzó L; Tiszlavicz L
    Orv Hetil; 2001 Mar; 142(11):547-55. PubMed ID: 11305232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
    Barton MB; Gabriel GS; Miles S
    ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of carcinoembryonic antigen in the management of advanced colorectal cancer.
    Mitchell EP
    Semin Oncol; 1998 Oct; 25(5 Suppl 11):12-20. PubMed ID: 9786312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What can be done to improve the results in colorectal cancer?
    Goligher JC
    Scand J Gastroenterol Suppl; 1988; 149():190-9. PubMed ID: 3059458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of second-look operations in colorectal cancer].
    Saitoh N; Miyazaki M; Sarashina H; Nunomura M; Yokoyama M; Inoue I; Ihara M; Nakayama H; Oda N; Shirai Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1289-94. PubMed ID: 2471456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
    Forslund A; Engarås B; Lönnroth C; Lundholm K
    Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Colorectal cancer. A better screening, a better treatment].
    Rougier P
    Rev Prat; 2004 Jan; 54(2):133-4. PubMed ID: 15086054
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinoembryonic antigen screening: pros and cons.
    Macdonald JS
    Semin Oncol; 1999 Oct; 26(5):556-60. PubMed ID: 10528904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standards, options and recommendations for tumor markers in colorectal cancer].
    Eche N; Pichon MF; Quillien V; Gory-Delabaere G; Riedinger JM; Basuyau JP; Daver A; Buecher B; Conroy T; Dieu L; Bidart JM; Deneux L;
    Bull Cancer; 2001 Dec; 88(12):1177-206. PubMed ID: 11792611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preoperative and postoperative CEA predict survival after colon cancer resection?
    Slentz K; Senagore A; Hibbert J; Mazier WP; Talbott TM
    Am Surg; 1994 Jul; 60(7):528-31; discussion 531-2. PubMed ID: 8010568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative borderline elevated CEA predicts for earlier relapse in patients with rectal cancer receiving adjuvant postoperative therapy.
    Dawson LA; Franssen E; Davey P
    Cancer J Sci Am; 1999; 5(6):374-9. PubMed ID: 10606480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of follow-up in colorectal cancer: second look guided by carcinoembryonic antigen (CEA) and secondary neoplasms].
    Marcuello Gaspar E; Manuel Nogueras F; Sánchez Parra M; Gajo Reyero R; Germá Lluch JR; Salvador Navarro R; Garriga Viayna J
    Rev Esp Enferm Apar Dig; 1988 Nov; 74(5):535-9. PubMed ID: 3238157
    [No Abstract]   [Full Text] [Related]  

  • 18. Colorectal cancer. Part 2: Treatment.
    Lunn D; Hurrell C; Campbell T
    Prof Nurse; 1999 Oct; 15(1):51-7. PubMed ID: 10595181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of liver and lung metastases from colorectal cancer].
    Burcharth F; Jensen BV
    Ugeskr Laeger; 2005 Nov; 167(45):4268-72. PubMed ID: 16277926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
    Kos J; Nielsen HJ; Krasovec M; Christensen IJ; Cimerman N; Stephens RW; Brünner N
    Clin Cancer Res; 1998 Jun; 4(6):1511-6. PubMed ID: 9626470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.